HomeSRT • ETR
add
Sartorius AG
Previous close
€186.60
Day range
€180.00 - €188.20
Year range
€131.40 - €230.00
Market cap
15.36B EUR
Avg Volume
4.82K
P/E ratio
122.22
Dividend yield
0.39%
Primary exchange
ETR
In the news
Financials
Income Statement
Revenue
Net income
| (EUR) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 843.20M | 6.25% |
Operating expense | 263.60M | -4.80% |
Net income | 43.80M | 208.45% |
Net profit margin | 5.19 | 189.94% |
Earnings per share | 1.08 | 24.14% |
EBITDA | 233.20M | 37.50% |
Effective tax rate | 26.94% | — |
Balance Sheet
Total assets
Total liabilities
| (EUR) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 389.90M | -32.68% |
Total assets | 9.61B | -1.84% |
Total liabilities | 5.80B | -3.60% |
Total equity | 3.81B | — |
Shares outstanding | — | — |
Price to book | — | — |
Return on assets | 3.30% | — |
Return on capital | 3.92% | — |
Cash Flow
Net change in cash
| (EUR) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | 43.80M | 208.45% |
Cash from operations | 221.60M | -16.72% |
Cash from investing | -210.90M | -125.56% |
Cash from financing | -440.80M | -136.73% |
Net change in cash | -429.00M | -3,505.04% |
Free cash flow | -12.04M | -115.50% |
About
Sartorius AG is an international pharmaceutical and laboratory equipment supplier. In September 2021, Sartorius was admitted to the DAX, Germany's largest stock market index. Sartorius develops and produces biotech drugs and vaccines. The company has two major divisions: Bioprocess Solutions and Lab Products & Services. Wikipedia
Founded
1870
Website
Employees
13,878
